Insider · CIK 0002023175
Marc Schwabish
Files at TECX (AVROBIO, Inc.). First filing -, latest -.
In brief
Marc Schwabish files SEC Form 4 as officer at TECX (AVROBIO, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marc Schwabish has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | TECX AVROBIO, Inc. | FTax withholding Common Stock | -411 | $23.67 | $9,728 | 44,903 | 11 d ago |
| Sep 3, 2026 | TECX AVROBIO, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +17,750 | $0.00 | $0 | 17,750 | 35 d ago |
| Mar 4, 2026 | TECX AVROBIO, Inc. | AGrant or award Common Stock | +19,500 | $0.00 | $0 | 45,314 | Mar 5, 2026 |
| Mar 4, 2026 | TECX AVROBIO, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +17,750 | $0.00 | $0 | 17,750 | Mar 5, 2026 |
| Feb 10, 2026 | TECX AVROBIO, Inc. | MOption exercise Common Stock | +4,500 | $2.38 | $11k | 25,814 | Feb 12, 2026 |
| Feb 10, 2026 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -4,500 | - | - | 82,014 | Feb 12, 2026 |
| Feb 4, 2026 | TECX AVROBIO, Inc. | FTax withholding Common Stock | -1,619 | $23.22 | $38k | 21,314 | Feb 10, 2026 |
| Sep 25, 2025 | TECX AVROBIO, Inc. | AGrant or award Common Stock | +4,210 | $0.00 | $0 | 22,933 | Sep 29, 2025 |
| Sep 25, 2025 | TECX AVROBIO, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +7,650 | $0.00 | $0 | 7,650 | Sep 29, 2025 |
| Dec 9, 2024 | TECX AVROBIO, Inc. | MOption exercise Common Stock | +2,000 | $2.38 | $4,760 | 2,000 | Dec 11, 2024 |
| Dec 9, 2024 | TECX AVROBIO, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,000 | - | - | 89,214 | Dec 11, 2024 |
Questions about Marc Schwabish
Answered from the filings on this page, as of the latest one.
Is Marc Schwabish buying or selling?
Marc Schwabish has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marc Schwabish's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marc Schwabish has 0.
Where does Marc Schwabish file Form 4?
Marc Schwabish has filed Form 4 at TECX (AVROBIO, Inc.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.